Abstract
Multiple karyotypic abnormalities and chromosomal instability are characteristic features of many cancers that are relatively resistant to chemotherapeutic agents currently used in the clinic. These same features represent potentially targetable “states” that are essentially tumor specific. The assessment of the chromosomal state of a cancer cell population may provide a guide for the selection or development of drugs active against aggressive and intractable cancers.
Keywords: Aneuploidy, Chromosomal instability, Cancer, Anticancer drugs, NCI-60, Karyotic abnormalities, CIN, Chromosomal instability phenotype, Heterogeneity, Cancer progression, Chemotherpeutic agents, Anticancer therapy, Drosophila, Trisomies, Saccharomyces cerevisiae, Schizosaccharomyces pombe, Neoplasia, Tumorigenesis, Microsatellite instability, CENP-E heterozygous, Chromatid cohesion, Centrosomes, Kinetochore, Chromosome missegregating, JAK-STAT signaling pathways, ECM-receptor interaction pathways, Griseofulvin, Cancer spectrum, GI50 data vectors, Anthracyclines, Antifolates, Alkylators, Topoisomerase agents, Gemcitabine, 5-fluorouracil, Mercapto-3H quinazolines
Current Drug Targets
Title: Targeting Karyotypic Complexity and Chromosomal Instability of Cancer Cells
Volume: 11 Issue: 10
Author(s): Anna V. Roschke and Ilan R. Kirsch
Affiliation:
Keywords: Aneuploidy, Chromosomal instability, Cancer, Anticancer drugs, NCI-60, Karyotic abnormalities, CIN, Chromosomal instability phenotype, Heterogeneity, Cancer progression, Chemotherpeutic agents, Anticancer therapy, Drosophila, Trisomies, Saccharomyces cerevisiae, Schizosaccharomyces pombe, Neoplasia, Tumorigenesis, Microsatellite instability, CENP-E heterozygous, Chromatid cohesion, Centrosomes, Kinetochore, Chromosome missegregating, JAK-STAT signaling pathways, ECM-receptor interaction pathways, Griseofulvin, Cancer spectrum, GI50 data vectors, Anthracyclines, Antifolates, Alkylators, Topoisomerase agents, Gemcitabine, 5-fluorouracil, Mercapto-3H quinazolines
Abstract: Multiple karyotypic abnormalities and chromosomal instability are characteristic features of many cancers that are relatively resistant to chemotherapeutic agents currently used in the clinic. These same features represent potentially targetable “states” that are essentially tumor specific. The assessment of the chromosomal state of a cancer cell population may provide a guide for the selection or development of drugs active against aggressive and intractable cancers.
Export Options
About this article
Cite this article as:
V. Roschke Anna and R. Kirsch Ilan, Targeting Karyotypic Complexity and Chromosomal Instability of Cancer Cells, Current Drug Targets 2010; 11 (10) . https://dx.doi.org/10.2174/1389450111007011341
DOI https://dx.doi.org/10.2174/1389450111007011341 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Curcumin: Not So Spicy After All
Mini-Reviews in Medicinal Chemistry Rhodanine as a Privileged Scaffold in Drug Discovery
Current Medicinal Chemistry Insulin-Like Growth Factor 2 - The Oncogene and its Accomplices
Current Pharmaceutical Design Calpain-Associated Proteolytic Regulation of the Stromal Microenvironment in Cancer
Current Pharmaceutical Design Targeting the Tumor Proteasome as a Mechanism to Control the Synthesis and Bioactivity of Matrix Macromolecules
Current Molecular Medicine Effect of Oil Extract from Microalgae (<i>Schizochytrium</i> sp.) on the Viability and Apoptosis of Human Osteosarcoma Cells
Current Pharmaceutical Biotechnology Commercial Availability of Alpha-Emitting Radionuclides for Medicine
Current Radiopharmaceuticals The Immunoregulatory Protein Human B7H3 is a Tumor-Associated Antigen that Regulates Tumor Cell Migration and Invasion
Current Cancer Drug Targets Serpins for Diagnosis and Therapy in Cancer
Cardiovascular & Hematological Disorders-Drug Targets The Urokinase-type Plasminogen Activator and the Generation of Inhibitors of Urokinase Activity and Signaling
Current Pharmaceutical Design MicroRNA Regulation of TRAIL in Renal Carcinoma: Tiny Juggernauts at Work
Current Molecular Pharmacology Transductional and Transcriptional Targeting of Adenovirus for Clinical Applications
Current Gene Therapy iPSCs Derived from Malignant Tumor Cells: Potential Application for Cancer Research
Current Stem Cell Research & Therapy Non-Viral Gene Delivery to the Lungs
Current Gene Therapy Exploiting APC Function as a Novel Cancer Therapy
Current Drug Targets Hydrogels: A Journey from Diapers to Gene Delivery
Mini-Reviews in Medicinal Chemistry Magnetic Hyperthermia with Magnetic Nanoparticles: A Status Review
Current Topics in Medicinal Chemistry Automated Radiosynthesis and Molecular Docking Studies of Coumarin- Triazole Hybrid with fluorine-18: A feasibility study
Current Radiopharmaceuticals A Comprehensive Insight Towards Pharmaceutical Aspects of Graphene Nanosheets
Current Pharmaceutical Biotechnology Cancer/Testis Antigens Trigger Epithelial-Mesenchymal Transition and Genesis of Cancer Stem-Like Cells
Current Pharmaceutical Design